SanShantha Biotechnics

Shantha Biotechnics is a pioneering Indian biotechnology company based in Hyderabad, specializing in the development and manufacture of high-quality, affordable vaccines and biopharmaceuticals. Founded in 1993, it gained international recognition for developing Shanvac-B, India's first indigenous recombinant Hepatitis B vaccine. The company focuses on infectious diseases and maintains a robust portfolio of WHO-prequalified vaccines, including pentavalent and oral cholera vaccines. Since 2009, it has operated as a wholly-owned subsidiary of Sanofi, serving as a critical manufacturing hub for global immunization programs. Its facilities are equipped for large-scale biologics production and meet stringent international regulatory standards, supporting healthcare access in emerging markets.